Company / Assets per Share
NeoGenomics Laboratories, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$10.62
FY2025
5-year range
$10.62 / $15.59
FY2021-FY2025
Trend
-17.9%
vs FY2024
Sector context
#125 of 158
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s assets per share of $10.62 is lower than 79% of companies in the Health Care sector (FY2025). Assets per Share has declined for 4 consecutive years, from $15.59 in FY2021 to $10.62 in FY2025.
Based on SEC 10-K filings.
10.62 in FY2025 with a 5-year CAGR of +3.7%.
Declined from $13.40 to $10.62 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 158This company $10.62 Sector average $116.83
▼
-90.9% below sector average
Key checks
Key Insights
- NeoGenomics Laboratories, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 17.9% year-over-year.
- Ranks #125 out of 158 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.62 | -17.9% |
| FY2024 | $12.93 | -3.5% |
| FY2023 | $13.40 | -4.4% |
| FY2022 | $14.01 | -10.1% |
| FY2021 | $15.59 | +76.3% |
| FY2020 | $8.84 | +29.1% |
| FY2019 | $6.85 | +24.2% |
| FY2018 | $5.52 | +25.8% |
| FY2017 | $4.38 | -1.4% |
| FY2016 | $4.45 | -23.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026